FDA reports shortage of Novo Nordisk's weight loss drug Saxenda
Novo Nordisk is facing another shortage of one of its blockbuster drugs; this time it’s the weight loss drug liraglutide, better known as Saxenda. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
